×
  • Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Closed System Drug Transfer Device Market Analysis

    ID: MRFR/HC/6264-CR
    146 Pages
    Rahul Gotadki
    March 2024

    Closed System Drug Transfer Device Market Research Report Information By type (Membrane to Membrane and Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Closed System Drug Transfer Device Market Infographic
    Purchase Options
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Analysis

    In-depth Analysis of Closed System Drug Transfer Device Market Industry Landscape

    The high demand for Closed System Drug Transfer Devices (CSTDs) in the healthcare industry is mainly due to strict rules set by regulatory agencies. One of these agencies is the U.S. Food and Drug Administration (FDA), which has established detailed guidelines to ensure the safe handling and administration of dangerous drugs. These rules apply to various healthcare settings, such as hospitals, clinics, and home healthcare. Adhering to these regulations requires the widespread use of CSTDs, which play a crucial role in following safety protocols. The primary goal is to protect healthcare workers, patients, and the environment from being exposed to harmful substances. Because of this, healthcare facilities prioritize the adoption of CSTDs to create a secure system during drug transfer, minimizing the risk of contamination and negative health effects.

    The strict regulatory environment not only emphasizes the necessity of CSTDs but also encourages advancements in their design and functionality. Manufacturers constantly improve CSTD technology to not only meet but exceed these regulations. This continuous innovation results in more advanced and user-friendly devices. Therefore, the combination of stringent regulatory requirements and a strong commitment to safety has led to the widespread acceptance of CSTDs as a crucial safeguard in the healthcare system. They ensure the safe handling and administration of dangerous drugs while upholding the highest standards of patient and healthcare worker safety.

    Regulatory agencies, especially the FDA, play a pivotal role in shaping the landscape for CSTDs. Their guidelines act as a driving force for innovation in the design and features of these devices. As a result, CSTDs have evolved to become more sophisticated, addressing not only the basic safety requirements but also enhancing user experience and ease of use.

    One of the key motivations behind the adoption of CSTDs is the imperative to protect those involved in the healthcare process. Healthcare workers, who are on the front lines of drug administration, face potential risks of exposure to hazardous substances. Patients, too, can be at risk if proper precautions are not taken during drug transfer. Moreover, there is a growing awareness of the environmental impact of improper handling of these substances. CSTDs, by creating a closed and secure system, effectively address these concerns, making them an integral part of healthcare practices.

    The significance of CSTDs goes beyond mere compliance with regulations; it reflects a broader commitment to fostering a culture of safety within the healthcare industry. The continuous improvements in CSTD technology are driven by the shared goal of ensuring that the administration of drugs, particularly hazardous ones, is carried out with the utmost care and precision. The evolving nature of these devices not only meets current regulatory requirements but also anticipates future challenges, making them a sustainable and reliable solution for the healthcare ecosystem.

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch

    Leave a Comment

    FAQs

    What is the projected market valuation of the Closed System Drug Transfer Device Market by 2035?

    The market is projected to reach approximately 3.483 USD Billion by 2035.

    What was the market valuation of the Closed System Drug Transfer Device Market in 2024?

    The market valuation was 1.2 USD Billion in 2024.

    What is the expected CAGR for the Closed System Drug Transfer Device Market during the forecast period 2025 - 2035?

    The expected CAGR for the market during this period is 10.17%.

    Which companies are considered key players in the Closed System Drug Transfer Device Market?

    Key players include Baxter International Inc, B. Braun Melsungen AG, and ICU Medical Inc, among others.

    What are the main types of Closed System Drug Transfer Devices and their market values?

    Membrane-To-Membrane Systems and Needleless Systems each had a market value of 0.6 USD Billion in 2024, projected to grow to 1.74 and 1.743 USD Billion respectively by 2035.

    Market Summary

    As per MRFR analysis, the Closed System Drug Transfer Device Market was estimated at 1.2 USD Billion in 2024. The Closed System Drug Transfer Device industry is projected to grow from 1.322 in 2025 to 3.483 by 2035, exhibiting a compound annual growth rate (CAGR) of 10.17 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Closed System Drug Transfer Device Market is poised for substantial growth driven by technological advancements and increasing safety awareness.

    • North America remains the largest market for closed system drug transfer devices, reflecting a strong emphasis on regulatory compliance and safety standards.
    • The Asia-Pacific region is emerging as the fastest-growing market, driven by rising healthcare investments and an expanding patient population.
    • Membrane-to-membrane systems dominate the market, while needleless systems are experiencing rapid growth due to their enhanced safety features.
    • Technological innovations and an increased focus on occupational health are key drivers propelling the demand for closed system drug transfer devices.

    Market Size & Forecast

    2024 Market Size 1.2 (USD Billion)
    2035 Market Size 3.483 (USD Billion)
    CAGR (2025 - 2035) 10.17%
    Largest Regional Market Share in 2024 North America

    Major Players

    <p>Baxter International Inc (US), B. Braun Melsungen AG (DE), Calea (GB), ICU Medical Inc (US), Corvida Medical (US), Equashield LLC (US), Teva Pharmaceutical Industries Ltd (IL), Fresenius Kabi AG (DE), McKesson Corporation (US)</p>

    Market Trends

    The Closed System Drug Transfer Device Market is currently experiencing a notable evolution, driven by increasing awareness regarding safety protocols in healthcare settings. This market encompasses devices designed to prevent contamination during the handling of hazardous drugs, thereby safeguarding healthcare professionals and patients alike. As regulatory bodies emphasize stringent safety measures, the demand for these devices appears to be on the rise. Furthermore, advancements in technology are likely to enhance the functionality and efficiency of these systems, making them more appealing to healthcare providers. In addition, the growing prevalence of chronic diseases necessitates the need for effective drug delivery systems, which may further propel the Closed System Drug Transfer Device Market. The integration of innovative designs and user-friendly features could potentially attract a broader range of users, from hospitals to outpatient facilities. As the market continues to evolve, it seems poised for substantial growth, reflecting the ongoing commitment to improving safety standards in drug administration. Stakeholders in this sector must remain vigilant to emerging trends and adapt accordingly to maintain a competitive edge.

    Technological Advancements

    The Closed System Drug Transfer Device Market is witnessing a surge in technological innovations. New designs and materials are being developed to enhance safety and usability. These advancements may lead to more efficient drug transfer processes, reducing the risk of exposure to hazardous substances.

    Regulatory Compliance

    Increasing regulatory scrutiny is shaping the Closed System Drug Transfer Device Market. Healthcare facilities are compelled to adhere to stringent safety guidelines, which may drive the adoption of these devices. Compliance with regulations could become a key factor influencing purchasing decisions.

    Rising Awareness of Safety

    There is a growing awareness regarding the importance of safety in drug handling. This trend is likely to boost the demand for Closed System Drug Transfer Devices as healthcare professionals seek to minimize risks associated with hazardous drug exposure. Enhanced education and training may further support this shift.

    <p>The increasing emphasis on safety and efficacy in drug handling practices appears to drive the adoption of closed system drug transfer devices across healthcare settings.</p>

    U.S. Food and Drug Administration (FDA)

    Closed System Drug Transfer Device Market Market Drivers

    Regulatory Compliance

    Regulatory compliance plays a crucial role in shaping the Closed System Drug Transfer Device Market. Governments and health organizations are implementing stringent guidelines to ensure the safe handling of hazardous drugs. Compliance with these regulations is not only mandatory but also enhances the credibility of healthcare providers. The market is influenced by the need for devices that meet these regulatory standards, which can lead to increased adoption rates. As a result, manufacturers are focusing on developing products that align with these regulations, thereby driving growth in the Closed System Drug Transfer Device Market.

    Rising Demand for Safety

    The rising demand for safety in healthcare settings is a significant driver for the Closed System Drug Transfer Device Market. Healthcare professionals are increasingly aware of the risks associated with handling hazardous drugs, leading to a greater emphasis on safety protocols. This heightened awareness is prompting hospitals and clinics to invest in closed system devices that minimize the risk of contamination and exposure. Market data indicates that the demand for these devices is expected to rise, with a projected increase in sales by 20% over the next few years. This trend underscores the importance of safety in the Closed System Drug Transfer Device Market.

    Technological Innovations

    The Closed System Drug Transfer Device Market is experiencing a surge in technological innovations that enhance safety and efficiency in drug handling. Advanced designs, such as needle-free systems and automated transfer devices, are being developed to minimize the risk of exposure to hazardous drugs. These innovations not only improve user experience but also comply with stringent safety regulations. The market is projected to grow at a compound annual growth rate of approximately 15% over the next five years, driven by these advancements. As healthcare facilities increasingly adopt these technologies, the Closed System Drug Transfer Device Market is likely to witness significant expansion.

    Expansion of Oncology Treatments

    The expansion of oncology treatments is significantly influencing the Closed System Drug Transfer Device Market. As the prevalence of cancer continues to rise, there is an increasing need for safe and effective drug delivery systems. Closed system drug transfer devices are essential in oncology settings, where the handling of cytotoxic drugs poses substantial risks. Market analysts project that the oncology segment will account for a considerable share of the Closed System Drug Transfer Device Market, with growth rates expected to exceed 18% in the coming years. This trend highlights the critical role of these devices in ensuring safe drug administration in oncology.

    Increased Focus on Occupational Health

    An increased focus on occupational health within healthcare environments is driving the Closed System Drug Transfer Device Market. Healthcare workers are at risk of exposure to hazardous drugs, which can lead to serious health issues. As organizations prioritize the well-being of their staff, there is a growing demand for closed system drug transfer devices that protect healthcare professionals from potential harm. This shift in focus is likely to result in a substantial increase in the adoption of these devices, contributing to the overall growth of the Closed System Drug Transfer Device Market.

    Market Segment Insights

    By Type: Membrane-To-Membrane Systems (Largest) vs. Needleless Systems (Fastest-Growing)

    <p>In the Closed System Drug Transfer Device Market, Membrane-To-Membrane Systems hold the largest market share, attributed to their efficiency and safety in transferring hazardous drugs. This segment has established a strong foothold due to robust demand from healthcare facilities aiming to reduce the risk of contamination during drug preparation. In contrast, Needleless Systems are gaining traction, appealing to providers focused on minimizing needle stick injuries and enhancing patient safety. Their share is increasing as healthcare institutions adopt innovative methods to streamline procedures and improve safety protocols.</p>

    <p>Type: Membrane-To-Membrane Systems (Dominant) vs. Needleless Systems (Emerging)</p>

    <p>Membrane-To-Membrane Systems are at the forefront of the Closed System Drug Transfer Device Market, characterized by their specialized design that ensures secure drug transfer while minimizing the risk of exposure. These systems are preferred in hospitals and oncology settings, where safety is paramount. On the other hand, Needleless Systems are emerging as a preferred alternative due to their ability to eliminate the use of needles, which significantly reduces the risk of needlestick injuries. As more healthcare providers focus on safety and efficiency, the demand for Needleless Systems is rapidly increasing, indicating a shift towards more innovative and user-friendly drug delivery methods.</p>

    By Component: Vial Access Devices (Largest) vs. Syringe Safety Devices (Fastest-Growing)

    <p>In the Closed System Drug Transfer Device Market, the Component segment encompasses a variety of devices designed to enhance safety and efficiency in drug handling. Vial Access Devices hold the largest market share, driven by their established use in hospitals and pharmacies for safe drug preparation and transfer. On the other hand, Syringe Safety Devices are quickly gaining traction, representing the fastest-growing segment due to increasing awareness of needle-stick injuries and the demand for safer healthcare practices among medical professionals. The growth of the Component segment is associated with advancements in technology and the rising focus on patient safety and workplace safety regulations. As healthcare providers continue to prioritize the reduction of contamination risks and increase medication safety, the demand for both Vial Access and Syringe Safety Devices is expected to rise. Bag/Line Access Devices and Accessories are also important, although they presently occupy a smaller share. Innovations in product design and functionality are anticipated to drive future growth across all components of this segment.</p>

    <p>Vial Access Devices (Dominant) vs. Syringe Safety Devices (Emerging)</p>

    <p>Vial Access Devices serve as the cornerstone of the Closed System Drug Transfer Device Market, providing safe access to medications while minimizing contamination risks. Their dominant position is bolstered by decades of usage in various healthcare settings, ensuring reliability and trust among practitioners. The introduction of advanced features, such as enhanced sterility and user-friendly mechanisms, keeps these devices at the forefront of the market. Conversely, Syringe Safety Devices are emerging as a critical component due to their potential to significantly reduce needle-stick injuries, a prevalent issue in healthcare environments. The growing emphasis on patient and healthcare worker safety has fueled innovation in this area, resulting in an array of devices designed with safety-engineering principles. As more healthcare facilities adapt to regulatory pressures and safety standards, the popularity of Syringe Safety Devices is set to expand, marking a notable trend in the industry.</p>

    By Closing Mechanism: Push To Turn System (Largest) vs. Click-To Lock System (Fastest-Growing)

    <p>In the Closed System Drug Transfer Device Market, the Push To Turn System currently stands as the largest segment, commanding significant market share due to its robust design and ease of use in healthcare settings. Following closely is the Color-To-Color Alignment System, which has carved out a notable presence by ensuring safety and reducing errors during drug transfers. Other systems like Luer Lock and Click-To Lock represent a smaller share but are crucial for specific applications, illustrating a varied landscape in closing mechanisms.</p>

    <p>Push To Turn System (Dominant) vs. Click-To Lock System (Emerging)</p>

    <p>The Push To Turn System is recognized for its reliability and user-friendly operation, making it the preferred choice among healthcare professionals. It excels in providing secure connections for drug transfer, promoting patient safety and minimizing contamination risks. On the other hand, the Click-To Lock System is emerging rapidly due to its innovative design, ensuring a quick and secure fit that appeals to modern healthcare practices. Its growing adoption is driven by the push for efficiency and safety in drug handling, making it a significant contender as healthcare facilities seek advanced solutions.</p>

    By Technology: Diaphragm-Based Devices (Largest) vs. Compartmentalize Devices (Fastest-Growing)

    <p>In the Closed System Drug Transfer Device Market, Diaphragm-Based Devices hold the largest share due to their proven efficacy in preventing contamination during drug transfer. This type of device is widely adopted in healthcare settings, which enhances its market presence. Compartmentalize Devices, on the other hand, are gaining traction with increased focus on safety and efficiency, contributing to their rapid market growth. Their innovative designs appeal to healthcare providers looking for enhanced functionality and safety features. The growth of Diaphragm-Based Devices is supported by the rising number of regulations around drug safety and preparation, which drive adoption rates. In contrast, Compartmentalize Devices are emerging as the fastest-growing segment, with advancements in technology enhancing their usability. The increasing prevalence of hazardous drug handling in healthcare also propels demand for both device types, as institutions prioritize protecting healthcare workers and ensuring compliant drug transfer processes.</p>

    <p>Technology: Diaphragm-Based Devices (Dominant) vs. Compartmentalize Devices (Emerging)</p>

    <p>Diaphragm-Based Devices continue to dominate the Closed System Drug Transfer Device Market due to their reliability and safety profile. These devices feature robust designs that minimize risks associated with harmful drug exposure, making them a preferred choice for healthcare institutions. In contrast, Compartmentalize Devices are viewed as an emerging alternative, providing innovative solutions that optimize drug transfer processes. Their unique structures lead to enhanced containment capability and operational efficiency, appealing to operators focused on decreasing contamination risks. While Diaphragm-Based Devices are established in the market, the increasing adoption of Compartmentalize Devices indicates a shifting landscape, where safety and advanced technology play crucial roles in shaping healthcare delivery.</p>

    By End User: Hospitals & Clinics (Largest) vs. Specialty Centers (Fastest-Growing)

    <p>In the Closed System Drug Transfer Device Market, the distribution of market share among end users reveals that Hospitals and Clinics hold a significant proportion, serving as the backbone of healthcare delivery. This segment benefits from a wide range of pharmaceutical services and a higher frequency of drug transfers, primarily due to the acute care needs of patients. Specialty Centers, while smaller in overall share, are rapidly gaining traction due to their focused services and specialized treatments that necessitate the use of closed system transfer devices. The growth trends in the end user segment are primarily driven by an increasing emphasis on safety protocols in hospitals and clinics, pushing the adoption of closed system devices to mitigate exposure to hazardous drugs. Additionally, the rise in specialty centers, particularly in fields like oncology and infusion therapy, contributes to the market's expansion as they prioritize patient safety and efficacy in drug delivery systems. The innovative development of these devices is a key factor that is expected to sustain growth in both segments, especially as regulations become more stringent.</p>

    <p>Hospitals & Clinics (Dominant) vs. Specialty Centers (Emerging)</p>

    <p>Hospitals and Clinics remain the dominant force in the Closed System Drug Transfer Device Market due to their extensive infrastructure and the volume of drug transfers conducted daily. These facilities are often the primary adopters of new technologies, including closed system devices, to enhance safety protocols and comply with regulatory standards. On the other hand, Specialty Centers, which offer focused services such as chemotherapy and chronic disease management, represent an emerging market segment. They are characterized by their tailored approach to treatment and a higher need for specialized drug transfer systems. This growing recognition of the unique needs of Specialty Centers drives innovation and development, positioning them as pivotal contributors to the market's evolution.</p>

    Get more detailed insights about Closed System Drug Transfer Device Market Research Report - Forecast till 2035

    Regional Insights

    North America : Market Leader in Innovation

    North America is the largest market for Closed System Drug Transfer Devices (CSTD), holding approximately 45% of the global market share. The region's growth is driven by stringent regulatory frameworks, increasing awareness of safety protocols, and a rising incidence of hazardous drug exposure among healthcare workers. The demand for advanced drug delivery systems is further fueled by the growing prevalence of chronic diseases and the need for efficient healthcare solutions. The United States is the primary contributor to this market, with key players like Baxter International Inc, ICU Medical Inc, and McKesson Corporation leading the competitive landscape. The presence of established healthcare infrastructure and significant investments in R&D enhance the region's market position. Additionally, the focus on improving patient safety and compliance with regulations continues to drive innovation in CSTD technologies.

    Europe : Regulatory Frameworks Drive Growth

    Europe is the second-largest market for Closed System Drug Transfer Devices, accounting for approximately 30% of the global share. The region's growth is propelled by increasing regulatory requirements aimed at ensuring the safety of healthcare professionals and patients. The European Medicines Agency (EMA) has implemented guidelines that mandate the use of CSTDs in specific healthcare settings, further boosting market demand. Leading countries in this region include Germany, France, and the United Kingdom, where major players like B. Braun Melsungen AG and Fresenius Kabi AG are actively involved. The competitive landscape is characterized by a mix of established companies and innovative startups, focusing on developing advanced CSTD solutions. The emphasis on patient safety and compliance with stringent regulations continues to shape the market dynamics in Europe.

    Asia-Pacific : Rapid Growth and Adoption

    Asia-Pacific is witnessing rapid growth in the Closed System Drug Transfer Device market, driven by increasing healthcare expenditures and a rising awareness of safety protocols. The region holds approximately 20% of the global market share, with countries like China and India leading the charge. The growing prevalence of chronic diseases and the expansion of healthcare infrastructure are significant factors contributing to this growth. China is emerging as a key player in the CSTD market, with local manufacturers and international companies like Teva Pharmaceutical Industries Ltd and Corvida Medical expanding their presence. The competitive landscape is evolving, with a focus on innovation and affordability. As regulatory bodies in the region begin to implement stricter safety guidelines, the demand for CSTDs is expected to rise significantly, further enhancing market opportunities.

    Middle East and Africa : Untapped Market Potential

    The Middle East and Africa region is gradually emerging in the Closed System Drug Transfer Device market, holding about 5% of the global share. The growth is primarily driven by increasing healthcare investments and a rising focus on patient safety. Governments in the region are beginning to recognize the importance of implementing safety measures in healthcare settings, which is expected to catalyze market growth in the coming years. Countries like South Africa and the UAE are at the forefront of this development, with a growing number of healthcare facilities adopting CSTDs. The competitive landscape is still developing, with opportunities for both local and international players to establish a foothold. As awareness of hazardous drug exposure increases, the demand for CSTDs is anticipated to grow, presenting significant opportunities for market expansion.

    Key Players and Competitive Insights

    The Closed System Drug Transfer Device Market is currently characterized by a dynamic competitive landscape, driven by increasing regulatory scrutiny and a heightened focus on safety in drug handling. Key players are actively pursuing strategies that emphasize innovation, regional expansion, and strategic partnerships to enhance their market positioning. For instance, Baxter International Inc (US) has been focusing on expanding its product portfolio through technological advancements, while B. Braun Melsungen AG (DE) is leveraging its strong global presence to penetrate emerging markets. These strategies collectively contribute to a competitive environment that is increasingly shaped by the need for enhanced safety protocols and efficient drug delivery systems.

    In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. The market structure appears moderately fragmented, with several players vying for market share. This fragmentation is indicative of a competitive environment where innovation and operational efficiency are paramount. The collective influence of key players, such as ICU Medical Inc (US) and Corvida Medical (US), is significant, as they continuously adapt to market demands and regulatory changes, thereby shaping the overall market dynamics.

    In August 2025, ICU Medical Inc (US) announced the launch of a new line of closed system drug transfer devices designed to enhance safety and efficiency in drug preparation. This strategic move is likely to bolster the company’s market share by addressing the growing demand for safer drug handling solutions. The introduction of this product line not only reflects ICU Medical's commitment to innovation but also positions the company favorably against competitors who may not have similar offerings.

    In September 2025, Corvida Medical (US) entered into a strategic partnership with a leading pharmaceutical company to co-develop advanced closed system drug transfer devices. This collaboration is expected to leverage both companies' strengths, potentially leading to enhanced product offerings and improved market penetration. Such partnerships are indicative of a trend where companies are seeking synergies to accelerate product development and meet evolving regulatory standards.

    Furthermore, in July 2025, B. Braun Melsungen AG (DE) expanded its manufacturing capabilities in Asia to better serve the growing demand in that region. This expansion is strategically important as it not only enhances the company’s operational efficiency but also positions it to capitalize on the increasing market opportunities in Asia. By localizing production, B. Braun is likely to reduce costs and improve supply chain reliability, which is crucial in a market where timely delivery is essential.

    As of October 2025, the competitive trends in the Closed System Drug Transfer Device Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, as companies recognize the need to collaborate to innovate and meet regulatory demands. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on technological innovation, enhanced safety features, and supply chain reliability. This shift suggests that companies that prioritize these aspects will likely gain a competitive edge in the market.

    Key Companies in the Closed System Drug Transfer Device Market market include

    Industry Developments

    December 2023: Equashield announced the launch of its latest product, the Mundus Mini HD. Leveraging Equashield’s CSTDs, the Mundus Mini HD aims to minimize contamination, exposure, and errors, thereby enhancing compounding safety and efficiency.

    October 2023: The EQUASHIELD Syringe Unit has received additional FDA clearance for full volume use.

    April 2022: Simplivia has launched Chemfort, its latest closed system transfer device (CSTD). Chemfort is designed to significantly minimize the risk of exposure for healthcare professionals during the preparation and administration of hazardous drugs.

    December 2021: B. Braun SE introduced the next generation OnGuard 2 CSTD in the US. Building on the strengths of its predecessor, OnGuard 2 incorporates upgraded materials and enhanced features aimed at improving usability while retaining all the existing advantages of the original OnGuard device.

    Future Outlook

    Closed System Drug Transfer Device Market Future Outlook

    <p>The Closed System Drug Transfer Device Market is projected to grow at a 10.17% CAGR from 2024 to 2035, driven by increasing safety regulations and rising demand for oncology drugs.</p>

    New opportunities lie in:

    • <p>Development of integrated telehealth solutions for remote drug administration.</p>
    • <p>Expansion into emerging markets with tailored product offerings.</p>
    • <p>Partnerships with pharmaceutical companies for co-branded drug delivery systems.</p>

    <p>By 2035, the market is expected to achieve substantial growth, solidifying its position as a critical component in healthcare.</p>

    Market Segmentation

    Closed System Drug Transfer Device Market Type Outlook

    • Membrane-To-Membrane Systems
    • Needleless Systems

    Closed System Drug Transfer Device Market End User Outlook

    • Hospitals & clinics
    • Specialty centers
    • Others

    Closed System Drug Transfer Device Market Component Outlook

    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Closed System Drug Transfer Device Market Technology Outlook

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices

    Closed System Drug Transfer Device Market Closing Mechanism Outlook

    • Push To Turn System
    • Color-To-Color Alignment System
    • Luer Lock Systems
    • Click-To Lock System

    Report Scope

    MARKET SIZE 20241.2(USD Billion)
    MARKET SIZE 20251.322(USD Billion)
    MARKET SIZE 20353.483(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)10.17% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesAdvancements in safety regulations drive demand for innovative Closed System Drug Transfer Device Market solutions.
    Key Market DynamicsRising regulatory scrutiny and technological advancements drive innovation in the Closed System Drug Transfer Device market.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    FAQs

    What is the projected market valuation of the Closed System Drug Transfer Device Market by 2035?

    The market is projected to reach approximately 3.483 USD Billion by 2035.

    What was the market valuation of the Closed System Drug Transfer Device Market in 2024?

    The market valuation was 1.2 USD Billion in 2024.

    What is the expected CAGR for the Closed System Drug Transfer Device Market during the forecast period 2025 - 2035?

    The expected CAGR for the market during this period is 10.17%.

    Which companies are considered key players in the Closed System Drug Transfer Device Market?

    Key players include Baxter International Inc, B. Braun Melsungen AG, and ICU Medical Inc, among others.

    What are the main types of Closed System Drug Transfer Devices and their market values?

    Membrane-To-Membrane Systems and Needleless Systems each had a market value of 0.6 USD Billion in 2024, projected to grow to 1.74 and 1.743 USD Billion respectively by 2035.

    1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
      1. | 1.1 EXECUTIVE SUMMARY
      2. | | 1.1.1 Market Overview
      3. | | 1.1.2 Key Findings
      4. | | 1.1.3 Market Segmentation
      5. | | 1.1.4 Competitive Landscape
      6. | | 1.1.5 Challenges and Opportunities
      7. | | 1.1.6 Future Outlook
    2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
      1. | 2.1 MARKET INTRODUCTION
      2. | | 2.1.1 Definition
      3. | | 2.1.2 Scope of the study
      4. | | | 2.1.2.1 Research Objective
      5. | | | 2.1.2.2 Assumption
      6. | | | 2.1.2.3 Limitations
      7. | 2.2 RESEARCH METHODOLOGY
      8. | | 2.2.1 Overview
      9. | | 2.2.2 Data Mining
      10. | | 2.2.3 Secondary Research
      11. | | 2.2.4 Primary Research
      12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
      13. | | | 2.2.4.2 Breakdown of Primary Respondents
      14. | | 2.2.5 Forecasting Model
      15. | | 2.2.6 Market Size Estimation
      16. | | | 2.2.6.1 Bottom-Up Approach
      17. | | | 2.2.6.2 Top-Down Approach
      18. | | 2.2.7 Data Triangulation
      19. | | 2.2.8 Validation
    3. SECTION III: QUALITATIVE ANALYSIS
      1. | 3.1 MARKET DYNAMICS
      2. | | 3.1.1 Overview
      3. | | 3.1.2 Drivers
      4. | | 3.1.3 Restraints
      5. | | 3.1.4 Opportunities
      6. | 3.2 MARKET FACTOR ANALYSIS
      7. | | 3.2.1 Value chain Analysis
      8. | | 3.2.2 Porter's Five Forces Analysis
      9. | | | 3.2.2.1 Bargaining Power of Suppliers
      10. | | | 3.2.2.2 Bargaining Power of Buyers
      11. | | | 3.2.2.3 Threat of New Entrants
      12. | | | 3.2.2.4 Threat of Substitutes
      13. | | | 3.2.2.5 Intensity of Rivalry
      14. | | 3.2.3 COVID-19 Impact Analysis
      15. | | | 3.2.3.1 Market Impact Analysis
      16. | | | 3.2.3.2 Regional Impact
      17. | | | 3.2.3.3 Opportunity and Threat Analysis
    4. SECTION IV: QUANTITATIVE ANALYSIS
      1. | 4.1 Healthcare, BY Type (USD Billion)
      2. | | 4.1.1 Membrane-To-Membrane Systems
      3. | | 4.1.2 Needleless Systems
      4. | 4.2 Healthcare, BY Component (USD Billion)
      5. | | 4.2.1 Vial Access Devices
      6. | | 4.2.2 Syringe Safety Devices
      7. | | 4.2.3 Bag/Line Access Devices
      8. | | 4.2.4 Accessories
      9. | 4.3 Healthcare, BY Closing Mechanism (USD Billion)
      10. | | 4.3.1 Push To Turn System
      11. | | 4.3.2 Color-To-Color Alignment System
      12. | | 4.3.3 Luer Lock Systems
      13. | | 4.3.4 Click-To Lock System
      14. | 4.4 Healthcare, BY Technology (USD Billion)
      15. | | 4.4.1 Compartmentalize Devices
      16. | | 4.4.2 Diaphragm-Based Devices
      17. | | 4.4.3 Air Filtration Devices
      18. | 4.5 Healthcare, BY End User (USD Billion)
      19. | | 4.5.1 Hospitals & clinics
      20. | | 4.5.2 Specialty centers
      21. | | 4.5.3 Others
      22. | 4.6 Healthcare, BY Region (USD Billion)
      23. | | 4.6.1 North America
      24. | | | 4.6.1.1 US
      25. | | | 4.6.1.2 Canada
      26. | | 4.6.2 Europe
      27. | | | 4.6.2.1 Germany
      28. | | | 4.6.2.2 UK
      29. | | | 4.6.2.3 France
      30. | | | 4.6.2.4 Russia
      31. | | | 4.6.2.5 Italy
      32. | | | 4.6.2.6 Spain
      33. | | | 4.6.2.7 Rest of Europe
      34. | | 4.6.3 APAC
      35. | | | 4.6.3.1 China
      36. | | | 4.6.3.2 India
      37. | | | 4.6.3.3 Japan
      38. | | | 4.6.3.4 South Korea
      39. | | | 4.6.3.5 Malaysia
      40. | | | 4.6.3.6 Thailand
      41. | | | 4.6.3.7 Indonesia
      42. | | | 4.6.3.8 Rest of APAC
      43. | | 4.6.4 South America
      44. | | | 4.6.4.1 Brazil
      45. | | | 4.6.4.2 Mexico
      46. | | | 4.6.4.3 Argentina
      47. | | | 4.6.4.4 Rest of South America
      48. | | 4.6.5 MEA
      49. | | | 4.6.5.1 GCC Countries
      50. | | | 4.6.5.2 South Africa
      51. | | | 4.6.5.3 Rest of MEA
    5. SECTION V: COMPETITIVE ANALYSIS
      1. | 5.1 Competitive Landscape
      2. | | 5.1.1 Overview
      3. | | 5.1.2 Competitive Analysis
      4. | | 5.1.3 Market share Analysis
      5. | | 5.1.4 Major Growth Strategy in the Healthcare
      6. | | 5.1.5 Competitive Benchmarking
      7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      8. | | 5.1.7 Key developments and growth strategies
      9. | | | 5.1.7.1 New Product Launch/Service Deployment
      10. | | | 5.1.7.2 Merger & Acquisitions
      11. | | | 5.1.7.3 Joint Ventures
      12. | | 5.1.8 Major Players Financial Matrix
      13. | | | 5.1.8.1 Sales and Operating Income
      14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
      15. | 5.2 Company Profiles
      16. | | 5.2.1 Baxter International Inc (US)
      17. | | | 5.2.1.1 Financial Overview
      18. | | | 5.2.1.2 Products Offered
      19. | | | 5.2.1.3 Key Developments
      20. | | | 5.2.1.4 SWOT Analysis
      21. | | | 5.2.1.5 Key Strategies
      22. | | 5.2.2 B. Braun Melsungen AG (DE)
      23. | | | 5.2.2.1 Financial Overview
      24. | | | 5.2.2.2 Products Offered
      25. | | | 5.2.2.3 Key Developments
      26. | | | 5.2.2.4 SWOT Analysis
      27. | | | 5.2.2.5 Key Strategies
      28. | | 5.2.3 Calea (GB)
      29. | | | 5.2.3.1 Financial Overview
      30. | | | 5.2.3.2 Products Offered
      31. | | | 5.2.3.3 Key Developments
      32. | | | 5.2.3.4 SWOT Analysis
      33. | | | 5.2.3.5 Key Strategies
      34. | | 5.2.4 ICU Medical Inc (US)
      35. | | | 5.2.4.1 Financial Overview
      36. | | | 5.2.4.2 Products Offered
      37. | | | 5.2.4.3 Key Developments
      38. | | | 5.2.4.4 SWOT Analysis
      39. | | | 5.2.4.5 Key Strategies
      40. | | 5.2.5 Corvida Medical (US)
      41. | | | 5.2.5.1 Financial Overview
      42. | | | 5.2.5.2 Products Offered
      43. | | | 5.2.5.3 Key Developments
      44. | | | 5.2.5.4 SWOT Analysis
      45. | | | 5.2.5.5 Key Strategies
      46. | | 5.2.6 Equashield LLC (US)
      47. | | | 5.2.6.1 Financial Overview
      48. | | | 5.2.6.2 Products Offered
      49. | | | 5.2.6.3 Key Developments
      50. | | | 5.2.6.4 SWOT Analysis
      51. | | | 5.2.6.5 Key Strategies
      52. | | 5.2.7 Teva Pharmaceutical Industries Ltd (IL)
      53. | | | 5.2.7.1 Financial Overview
      54. | | | 5.2.7.2 Products Offered
      55. | | | 5.2.7.3 Key Developments
      56. | | | 5.2.7.4 SWOT Analysis
      57. | | | 5.2.7.5 Key Strategies
      58. | | 5.2.8 Fresenius Kabi AG (DE)
      59. | | | 5.2.8.1 Financial Overview
      60. | | | 5.2.8.2 Products Offered
      61. | | | 5.2.8.3 Key Developments
      62. | | | 5.2.8.4 SWOT Analysis
      63. | | | 5.2.8.5 Key Strategies
      64. | | 5.2.9 McKesson Corporation (US)
      65. | | | 5.2.9.1 Financial Overview
      66. | | | 5.2.9.2 Products Offered
      67. | | | 5.2.9.3 Key Developments
      68. | | | 5.2.9.4 SWOT Analysis
      69. | | | 5.2.9.5 Key Strategies
      70. | 5.3 Appendix
      71. | | 5.3.1 References
      72. | | 5.3.2 Related Reports
    6. LIST OF FIGURES
      1. | 6.1 MARKET SYNOPSIS
      2. | 6.2 NORTH AMERICA MARKET ANALYSIS
      3. | 6.3 US MARKET ANALYSIS BY TYPE
      4. | 6.4 US MARKET ANALYSIS BY COMPONENT
      5. | 6.5 US MARKET ANALYSIS BY CLOSING MECHANISM
      6. | 6.6 US MARKET ANALYSIS BY TECHNOLOGY
      7. | 6.7 US MARKET ANALYSIS BY END USER
      8. | 6.8 CANADA MARKET ANALYSIS BY TYPE
      9. | 6.9 CANADA MARKET ANALYSIS BY COMPONENT
      10. | 6.10 CANADA MARKET ANALYSIS BY CLOSING MECHANISM
      11. | 6.11 CANADA MARKET ANALYSIS BY TECHNOLOGY
      12. | 6.12 CANADA MARKET ANALYSIS BY END USER
      13. | 6.13 EUROPE MARKET ANALYSIS
      14. | 6.14 GERMANY MARKET ANALYSIS BY TYPE
      15. | 6.15 GERMANY MARKET ANALYSIS BY COMPONENT
      16. | 6.16 GERMANY MARKET ANALYSIS BY CLOSING MECHANISM
      17. | 6.17 GERMANY MARKET ANALYSIS BY TECHNOLOGY
      18. | 6.18 GERMANY MARKET ANALYSIS BY END USER
      19. | 6.19 UK MARKET ANALYSIS BY TYPE
      20. | 6.20 UK MARKET ANALYSIS BY COMPONENT
      21. | 6.21 UK MARKET ANALYSIS BY CLOSING MECHANISM
      22. | 6.22 UK MARKET ANALYSIS BY TECHNOLOGY
      23. | 6.23 UK MARKET ANALYSIS BY END USER
      24. | 6.24 FRANCE MARKET ANALYSIS BY TYPE
      25. | 6.25 FRANCE MARKET ANALYSIS BY COMPONENT
      26. | 6.26 FRANCE MARKET ANALYSIS BY CLOSING MECHANISM
      27. | 6.27 FRANCE MARKET ANALYSIS BY TECHNOLOGY
      28. | 6.28 FRANCE MARKET ANALYSIS BY END USER
      29. | 6.29 RUSSIA MARKET ANALYSIS BY TYPE
      30. | 6.30 RUSSIA MARKET ANALYSIS BY COMPONENT
      31. | 6.31 RUSSIA MARKET ANALYSIS BY CLOSING MECHANISM
      32. | 6.32 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
      33. | 6.33 RUSSIA MARKET ANALYSIS BY END USER
      34. | 6.34 ITALY MARKET ANALYSIS BY TYPE
      35. | 6.35 ITALY MARKET ANALYSIS BY COMPONENT
      36. | 6.36 ITALY MARKET ANALYSIS BY CLOSING MECHANISM
      37. | 6.37 ITALY MARKET ANALYSIS BY TECHNOLOGY
      38. | 6.38 ITALY MARKET ANALYSIS BY END USER
      39. | 6.39 SPAIN MARKET ANALYSIS BY TYPE
      40. | 6.40 SPAIN MARKET ANALYSIS BY COMPONENT
      41. | 6.41 SPAIN MARKET ANALYSIS BY CLOSING MECHANISM
      42. | 6.42 SPAIN MARKET ANALYSIS BY TECHNOLOGY
      43. | 6.43 SPAIN MARKET ANALYSIS BY END USER
      44. | 6.44 REST OF EUROPE MARKET ANALYSIS BY TYPE
      45. | 6.45 REST OF EUROPE MARKET ANALYSIS BY COMPONENT
      46. | 6.46 REST OF EUROPE MARKET ANALYSIS BY CLOSING MECHANISM
      47. | 6.47 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
      48. | 6.48 REST OF EUROPE MARKET ANALYSIS BY END USER
      49. | 6.49 APAC MARKET ANALYSIS
      50. | 6.50 CHINA MARKET ANALYSIS BY TYPE
      51. | 6.51 CHINA MARKET ANALYSIS BY COMPONENT
      52. | 6.52 CHINA MARKET ANALYSIS BY CLOSING MECHANISM
      53. | 6.53 CHINA MARKET ANALYSIS BY TECHNOLOGY
      54. | 6.54 CHINA MARKET ANALYSIS BY END USER
      55. | 6.55 INDIA MARKET ANALYSIS BY TYPE
      56. | 6.56 INDIA MARKET ANALYSIS BY COMPONENT
      57. | 6.57 INDIA MARKET ANALYSIS BY CLOSING MECHANISM
      58. | 6.58 INDIA MARKET ANALYSIS BY TECHNOLOGY
      59. | 6.59 INDIA MARKET ANALYSIS BY END USER
      60. | 6.60 JAPAN MARKET ANALYSIS BY TYPE
      61. | 6.61 JAPAN MARKET ANALYSIS BY COMPONENT
      62. | 6.62 JAPAN MARKET ANALYSIS BY CLOSING MECHANISM
      63. | 6.63 JAPAN MARKET ANALYSIS BY TECHNOLOGY
      64. | 6.64 JAPAN MARKET ANALYSIS BY END USER
      65. | 6.65 SOUTH KOREA MARKET ANALYSIS BY TYPE
      66. | 6.66 SOUTH KOREA MARKET ANALYSIS BY COMPONENT
      67. | 6.67 SOUTH KOREA MARKET ANALYSIS BY CLOSING MECHANISM
      68. | 6.68 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
      69. | 6.69 SOUTH KOREA MARKET ANALYSIS BY END USER
      70. | 6.70 MALAYSIA MARKET ANALYSIS BY TYPE
      71. | 6.71 MALAYSIA MARKET ANALYSIS BY COMPONENT
      72. | 6.72 MALAYSIA MARKET ANALYSIS BY CLOSING MECHANISM
      73. | 6.73 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
      74. | 6.74 MALAYSIA MARKET ANALYSIS BY END USER
      75. | 6.75 THAILAND MARKET ANALYSIS BY TYPE
      76. | 6.76 THAILAND MARKET ANALYSIS BY COMPONENT
      77. | 6.77 THAILAND MARKET ANALYSIS BY CLOSING MECHANISM
      78. | 6.78 THAILAND MARKET ANALYSIS BY TECHNOLOGY
      79. | 6.79 THAILAND MARKET ANALYSIS BY END USER
      80. | 6.80 INDONESIA MARKET ANALYSIS BY TYPE
      81. | 6.81 INDONESIA MARKET ANALYSIS BY COMPONENT
      82. | 6.82 INDONESIA MARKET ANALYSIS BY CLOSING MECHANISM
      83. | 6.83 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
      84. | 6.84 INDONESIA MARKET ANALYSIS BY END USER
      85. | 6.85 REST OF APAC MARKET ANALYSIS BY TYPE
      86. | 6.86 REST OF APAC MARKET ANALYSIS BY COMPONENT
      87. | 6.87 REST OF APAC MARKET ANALYSIS BY CLOSING MECHANISM
      88. | 6.88 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
      89. | 6.89 REST OF APAC MARKET ANALYSIS BY END USER
      90. | 6.90 SOUTH AMERICA MARKET ANALYSIS
      91. | 6.91 BRAZIL MARKET ANALYSIS BY TYPE
      92. | 6.92 BRAZIL MARKET ANALYSIS BY COMPONENT
      93. | 6.93 BRAZIL MARKET ANALYSIS BY CLOSING MECHANISM
      94. | 6.94 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
      95. | 6.95 BRAZIL MARKET ANALYSIS BY END USER
      96. | 6.96 MEXICO MARKET ANALYSIS BY TYPE
      97. | 6.97 MEXICO MARKET ANALYSIS BY COMPONENT
      98. | 6.98 MEXICO MARKET ANALYSIS BY CLOSING MECHANISM
      99. | 6.99 MEXICO MARKET ANALYSIS BY TECHNOLOGY
      100. | 6.100 MEXICO MARKET ANALYSIS BY END USER
      101. | 6.101 ARGENTINA MARKET ANALYSIS BY TYPE
      102. | 6.102 ARGENTINA MARKET ANALYSIS BY COMPONENT
      103. | 6.103 ARGENTINA MARKET ANALYSIS BY CLOSING MECHANISM
      104. | 6.104 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
      105. | 6.105 ARGENTINA MARKET ANALYSIS BY END USER
      106. | 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
      107. | 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY COMPONENT
      108. | 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY CLOSING MECHANISM
      109. | 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
      110. | 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
      111. | 6.111 MEA MARKET ANALYSIS
      112. | 6.112 GCC COUNTRIES MARKET ANALYSIS BY TYPE
      113. | 6.113 GCC COUNTRIES MARKET ANALYSIS BY COMPONENT
      114. | 6.114 GCC COUNTRIES MARKET ANALYSIS BY CLOSING MECHANISM
      115. | 6.115 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
      116. | 6.116 GCC COUNTRIES MARKET ANALYSIS BY END USER
      117. | 6.117 SOUTH AFRICA MARKET ANALYSIS BY TYPE
      118. | 6.118 SOUTH AFRICA MARKET ANALYSIS BY COMPONENT
      119. | 6.119 SOUTH AFRICA MARKET ANALYSIS BY CLOSING MECHANISM
      120. | 6.120 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
      121. | 6.121 SOUTH AFRICA MARKET ANALYSIS BY END USER
      122. | 6.122 REST OF MEA MARKET ANALYSIS BY TYPE
      123. | 6.123 REST OF MEA MARKET ANALYSIS BY COMPONENT
      124. | 6.124 REST OF MEA MARKET ANALYSIS BY CLOSING MECHANISM
      125. | 6.125 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
      126. | 6.126 REST OF MEA MARKET ANALYSIS BY END USER
      127. | 6.127 KEY BUYING CRITERIA OF HEALTHCARE
      128. | 6.128 RESEARCH PROCESS OF MRFR
      129. | 6.129 DRO ANALYSIS OF HEALTHCARE
      130. | 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
      131. | 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
      132. | 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
      133. | 6.133 HEALTHCARE, BY TYPE, 2024 (% SHARE)
      134. | 6.134 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
      135. | 6.135 HEALTHCARE, BY COMPONENT, 2024 (% SHARE)
      136. | 6.136 HEALTHCARE, BY COMPONENT, 2024 TO 2035 (USD Billion)
      137. | 6.137 HEALTHCARE, BY CLOSING MECHANISM, 2024 (% SHARE)
      138. | 6.138 HEALTHCARE, BY CLOSING MECHANISM, 2024 TO 2035 (USD Billion)
      139. | 6.139 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
      140. | 6.140 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
      141. | 6.141 HEALTHCARE, BY END USER, 2024 (% SHARE)
      142. | 6.142 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
      143. | 6.143 BENCHMARKING OF MAJOR COMPETITORS
    7. LIST OF TABLES
      1. | 7.1 LIST OF ASSUMPTIONS
      2. | | 7.1.1
      3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      4. | | 7.2.1 BY TYPE, 2025-2035 (USD Billion)
      5. | | 7.2.2 BY COMPONENT, 2025-2035 (USD Billion)
      6. | | 7.2.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      7. | | 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      8. | | 7.2.5 BY END USER, 2025-2035 (USD Billion)
      9. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
      10. | | 7.3.1 BY TYPE, 2025-2035 (USD Billion)
      11. | | 7.3.2 BY COMPONENT, 2025-2035 (USD Billion)
      12. | | 7.3.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      13. | | 7.3.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      14. | | 7.3.5 BY END USER, 2025-2035 (USD Billion)
      15. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      16. | | 7.4.1 BY TYPE, 2025-2035 (USD Billion)
      17. | | 7.4.2 BY COMPONENT, 2025-2035 (USD Billion)
      18. | | 7.4.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      19. | | 7.4.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      20. | | 7.4.5 BY END USER, 2025-2035 (USD Billion)
      21. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      22. | | 7.5.1 BY TYPE, 2025-2035 (USD Billion)
      23. | | 7.5.2 BY COMPONENT, 2025-2035 (USD Billion)
      24. | | 7.5.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      25. | | 7.5.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      26. | | 7.5.5 BY END USER, 2025-2035 (USD Billion)
      27. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      28. | | 7.6.1 BY TYPE, 2025-2035 (USD Billion)
      29. | | 7.6.2 BY COMPONENT, 2025-2035 (USD Billion)
      30. | | 7.6.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      31. | | 7.6.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      32. | | 7.6.5 BY END USER, 2025-2035 (USD Billion)
      33. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      34. | | 7.7.1 BY TYPE, 2025-2035 (USD Billion)
      35. | | 7.7.2 BY COMPONENT, 2025-2035 (USD Billion)
      36. | | 7.7.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      37. | | 7.7.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      38. | | 7.7.5 BY END USER, 2025-2035 (USD Billion)
      39. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
      40. | | 7.8.1 BY TYPE, 2025-2035 (USD Billion)
      41. | | 7.8.2 BY COMPONENT, 2025-2035 (USD Billion)
      42. | | 7.8.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      43. | | 7.8.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      44. | | 7.8.5 BY END USER, 2025-2035 (USD Billion)
      45. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      46. | | 7.9.1 BY TYPE, 2025-2035 (USD Billion)
      47. | | 7.9.2 BY COMPONENT, 2025-2035 (USD Billion)
      48. | | 7.9.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      49. | | 7.9.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      50. | | 7.9.5 BY END USER, 2025-2035 (USD Billion)
      51. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      52. | | 7.10.1 BY TYPE, 2025-2035 (USD Billion)
      53. | | 7.10.2 BY COMPONENT, 2025-2035 (USD Billion)
      54. | | 7.10.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      55. | | 7.10.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      56. | | 7.10.5 BY END USER, 2025-2035 (USD Billion)
      57. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      58. | | 7.11.1 BY TYPE, 2025-2035 (USD Billion)
      59. | | 7.11.2 BY COMPONENT, 2025-2035 (USD Billion)
      60. | | 7.11.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      61. | | 7.11.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      62. | | 7.11.5 BY END USER, 2025-2035 (USD Billion)
      63. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      64. | | 7.12.1 BY TYPE, 2025-2035 (USD Billion)
      65. | | 7.12.2 BY COMPONENT, 2025-2035 (USD Billion)
      66. | | 7.12.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      67. | | 7.12.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      68. | | 7.12.5 BY END USER, 2025-2035 (USD Billion)
      69. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      70. | | 7.13.1 BY TYPE, 2025-2035 (USD Billion)
      71. | | 7.13.2 BY COMPONENT, 2025-2035 (USD Billion)
      72. | | 7.13.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      73. | | 7.13.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      74. | | 7.13.5 BY END USER, 2025-2035 (USD Billion)
      75. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
      76. | | 7.14.1 BY TYPE, 2025-2035 (USD Billion)
      77. | | 7.14.2 BY COMPONENT, 2025-2035 (USD Billion)
      78. | | 7.14.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      79. | | 7.14.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      80. | | 7.14.5 BY END USER, 2025-2035 (USD Billion)
      81. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
      82. | | 7.15.1 BY TYPE, 2025-2035 (USD Billion)
      83. | | 7.15.2 BY COMPONENT, 2025-2035 (USD Billion)
      84. | | 7.15.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      85. | | 7.15.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      86. | | 7.15.5 BY END USER, 2025-2035 (USD Billion)
      87. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      88. | | 7.16.1 BY TYPE, 2025-2035 (USD Billion)
      89. | | 7.16.2 BY COMPONENT, 2025-2035 (USD Billion)
      90. | | 7.16.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      91. | | 7.16.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      92. | | 7.16.5 BY END USER, 2025-2035 (USD Billion)
      93. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      94. | | 7.17.1 BY TYPE, 2025-2035 (USD Billion)
      95. | | 7.17.2 BY COMPONENT, 2025-2035 (USD Billion)
      96. | | 7.17.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      97. | | 7.17.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      98. | | 7.17.5 BY END USER, 2025-2035 (USD Billion)
      99. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      100. | | 7.18.1 BY TYPE, 2025-2035 (USD Billion)
      101. | | 7.18.2 BY COMPONENT, 2025-2035 (USD Billion)
      102. | | 7.18.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      103. | | 7.18.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      104. | | 7.18.5 BY END USER, 2025-2035 (USD Billion)
      105. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      106. | | 7.19.1 BY TYPE, 2025-2035 (USD Billion)
      107. | | 7.19.2 BY COMPONENT, 2025-2035 (USD Billion)
      108. | | 7.19.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      109. | | 7.19.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      110. | | 7.19.5 BY END USER, 2025-2035 (USD Billion)
      111. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      112. | | 7.20.1 BY TYPE, 2025-2035 (USD Billion)
      113. | | 7.20.2 BY COMPONENT, 2025-2035 (USD Billion)
      114. | | 7.20.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      115. | | 7.20.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      116. | | 7.20.5 BY END USER, 2025-2035 (USD Billion)
      117. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      118. | | 7.21.1 BY TYPE, 2025-2035 (USD Billion)
      119. | | 7.21.2 BY COMPONENT, 2025-2035 (USD Billion)
      120. | | 7.21.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      121. | | 7.21.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      122. | | 7.21.5 BY END USER, 2025-2035 (USD Billion)
      123. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      124. | | 7.22.1 BY TYPE, 2025-2035 (USD Billion)
      125. | | 7.22.2 BY COMPONENT, 2025-2035 (USD Billion)
      126. | | 7.22.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      127. | | 7.22.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      128. | | 7.22.5 BY END USER, 2025-2035 (USD Billion)
      129. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      130. | | 7.23.1 BY TYPE, 2025-2035 (USD Billion)
      131. | | 7.23.2 BY COMPONENT, 2025-2035 (USD Billion)
      132. | | 7.23.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      133. | | 7.23.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      134. | | 7.23.5 BY END USER, 2025-2035 (USD Billion)
      135. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      136. | | 7.24.1 BY TYPE, 2025-2035 (USD Billion)
      137. | | 7.24.2 BY COMPONENT, 2025-2035 (USD Billion)
      138. | | 7.24.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      139. | | 7.24.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      140. | | 7.24.5 BY END USER, 2025-2035 (USD Billion)
      141. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      142. | | 7.25.1 BY TYPE, 2025-2035 (USD Billion)
      143. | | 7.25.2 BY COMPONENT, 2025-2035 (USD Billion)
      144. | | 7.25.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      145. | | 7.25.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      146. | | 7.25.5 BY END USER, 2025-2035 (USD Billion)
      147. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      148. | | 7.26.1 BY TYPE, 2025-2035 (USD Billion)
      149. | | 7.26.2 BY COMPONENT, 2025-2035 (USD Billion)
      150. | | 7.26.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      151. | | 7.26.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      152. | | 7.26.5 BY END USER, 2025-2035 (USD Billion)
      153. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      154. | | 7.27.1 BY TYPE, 2025-2035 (USD Billion)
      155. | | 7.27.2 BY COMPONENT, 2025-2035 (USD Billion)
      156. | | 7.27.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      157. | | 7.27.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      158. | | 7.27.5 BY END USER, 2025-2035 (USD Billion)
      159. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      160. | | 7.28.1 BY TYPE, 2025-2035 (USD Billion)
      161. | | 7.28.2 BY COMPONENT, 2025-2035 (USD Billion)
      162. | | 7.28.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      163. | | 7.28.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      164. | | 7.28.5 BY END USER, 2025-2035 (USD Billion)
      165. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      166. | | 7.29.1 BY TYPE, 2025-2035 (USD Billion)
      167. | | 7.29.2 BY COMPONENT, 2025-2035 (USD Billion)
      168. | | 7.29.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      169. | | 7.29.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      170. | | 7.29.5 BY END USER, 2025-2035 (USD Billion)
      171. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      172. | | 7.30.1 BY TYPE, 2025-2035 (USD Billion)
      173. | | 7.30.2 BY COMPONENT, 2025-2035 (USD Billion)
      174. | | 7.30.3 BY CLOSING MECHANISM, 2025-2035 (USD Billion)
      175. | | 7.30.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
      176. | | 7.30.5 BY END USER, 2025-2035 (USD Billion)
      177. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
      178. | | 7.31.1
      179. | 7.32 ACQUISITION/PARTNERSHIP
      180. | | 7.32.1

    Closed System Drug Transfer Device Market Segmentation

    Global Closed System Drug Transfer Device Type Outlook (USD Billion, 2019-2032)

    • Membrane-To-Membrane Systems
    • Needleless Systems

    Global Closed System Drug Transfer Device Component Outlook (USD Billion, 2019-2032)

    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Global Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Global Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices

    Global Closed System Drug Transfer Device End-user Outlook (USD Billion, 2019-2032)

    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Global Closed System Drug Transfer Device Regional Outlook (USD Billion, 2019-2032

    North America Outlook (USD Billion, 2019-2032)

    North America Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    North America Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    North America Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    North America Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    North America Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    US Outlook (USD Billion, 2019-2032)

    US Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    US Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    US Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    US Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    US Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Canada Outlook (USD Billion, 2019-2032)

    Canada Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Canada Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Canada Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Canada Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Canada Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Mexico Outlook (USD Billion, 2019-2032)

    Mexico Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Mexico Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

     

     

    Mexico Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Mexico Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Mexico Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Europe Outlook (USD Billion, 2019-2032)

    Europe Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Europe Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Europe Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Europe Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Europe Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Germany Outlook (USD Billion, 2019-2032)

    Germany Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Germany Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Germany Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

     

     

    Germany Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Germany Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    France Outlook (USD Billion, 2019-2032)

    France Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    France Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    France Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    France Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    France Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    UK Outlook (USD Billion, 2019-2032)

    UK Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    UK Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    UK Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    UK Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    UK Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Italy Outlook (USD Billion, 2019-2032)

    Italy Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Italy Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Italy Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Italy Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Italy Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Contract Research Organizations (CROs)

    Spain Outlook (USD Billion, 2019-2032)

    Spain Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Spain Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Spain Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Spain Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Spain Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Rest Of Europe Outlook (USD Billion, 2019-2032)

    Rest of Europe Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Rest of Europe Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Rest of Europe Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Rest of Europe Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Rest of Europe Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Asia-Pacific Outlook (USD Billion, 2019-2032)

    Asia-Pacific Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Asia-Pacific Global Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Asia-Pacific Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Asia-Pacific Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Asia-Pacific Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    China Outlook (USD Billion, 2019-2032)

    China Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    China Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    China Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    China Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    China Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Japan Outlook (USD Billion, 2019-2032)

    Japan Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Japan Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Japan Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

     

     

    Japan Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Japan Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    India Outlook (USD Billion, 2019-2032)

    India Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    India Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    India Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    India Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    India Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Australia Outlook (USD Billion, 2019-2032)

    Australia Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Australia Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Australia Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Australia Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Australia Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Rest of Asia-Pacific Outlook (USD Billion, 2019-2032)

    Rest of Asia-Pacific Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Rest of Asia-Pacific Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Rest of Asia-Pacific Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Rest of Asia-Pacific Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Rest of Asia-Pacific Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Rest of the World Outlook (USD Billion, 2019-2032)

    Rest of World Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    Rest of the World Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Rest of the World Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Rest of the World Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Rest of World Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Middle East & Africa Outlook (USD Billion, 2019-2032)

    Middle East & Africa Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems

     

     

    Middle East & Africa Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    Middle East & Africa Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    Middle East & Africa Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    Middle East & Africa Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others

    South America Outlook (USD Billion, 2019-2032)

    South America Closed System Drug Transfer Device by Type
    • Membrane-To-Membrane Systems
    • Needleless Systems
    South America Closed System Drug Transfer Device by Component
    • Vial Access Devices
    • Syringe Safety Devices
    • Bag/Line Access Devices
    • Accessories

    South America Closed System Drug Transfer Device Closing Mechanism Outlook (USD Billion, 2019-2032)

    • Push To Turn System
    • Color-To-Color Alignment System
    • Leur Lock Systems
    • Click-To Lock System

    South America Closed System Drug Transfer Technology Outlook (USD Billion, 2019-2032)

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices
    South America Closed System Drug Transfer Device by End-user
    • Hospitals & Clinics
    • Specialty Centers
    • Others
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization ✓ ✓ ✓
    Direct Access to Analyst ✓ ✓ ✓
    Deliverable Format ✓ ✓ ✓
    Platform Access ✗ ✗ ✓
    Discount on Next Purchase 10% 15% 15%
    Printable Versions ✗ ✗ ✓